Supplementary Table 1. Optimal First-Line Immune Checkpoint Inhibitor Treatment in Lung Cancer: How to Choose?

Name: Supplementary Table 1. Optimal First-Line Immune Checkpoint Inhibitor Treatment in Lung Cancer: How to Choose?
Creator: Fung, Andrea S.; Robinson, Andrew; Kartolo, Baskoro
Published: 2022-01-12T00:00:00+08:00

Taylor & Francis Group2024-05-15 更新2026-04-16 收录

肿瘤免疫治疗

癌症临床试验

数据链接：

https://tandf.figshare.com/articles/dataset/Supplementary_Table_1_Optimal_First-Line_Immune_Checkpoint_Inhibitor_Treatment_in_Lung_Cancer_How_to_Choose_/18260366/1 数据链接链接失效反馈

官方服务：

资源简介：

<i>ICI-Related Phase III RCTs in Previously Untreated Advanced NSCLC without Driver Mutations</i>

提供机构：

Fung, Andrea S.; Robinson, Andrew; Kartolo, Baskoro

创建时间：

2022-01-12

Supplementary Table 1. Optimal First-Line Immune Checkpoint Inhibitor Treatment in Lung Cancer: How to Choose?

资源简介：

相关数据集